Review article: the gut microbiome in inflammatory bowel disease—avenues for microbial management.
Book chapter: Faecal Microbiota Transplantation as an Emerging Treatment in European Countries
Maida M, McIlroy J, Ianiro G, Cammarota G
In: Mastrantonio P, Rupnik M. (eds). Updates on Clostridium difficile in Europe. Advances in Experimental Medicine and Biology, vol 1050. Springer Cham.
Faecal microbiota transplantation as a treatment for inflammatory bowel disease: a national survey of adult and paediatric gastroenterologists in the UK
Mcilroy JR, Nalagatla N, Hansen R, Hold G
Frontline Gastroenterologt 2018; 1-6. Doi:10.1136/flgastro-2017-100936
Current and future targets for faecal microbiota transplantation
Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?
Towards an EU-wide suitable regulatory framework for faecally derived, industrially manufactured medicinal products
Mikkelsen TA, McIlroy JR, Mimiague M, Rouanet A, Sterkman L
United European Gastroenterology Journal 2020